Archive for August 24th, 2008

HRT & Quality of Life

Health related quality of life after combined hormone replacement therapy: randomised controlled trial

BMJ 2008;337:a1190  

Objective To assess the effect of combined hormone replacement therapy (HRT) on health related quality of life.

                                       1

Design Randomised placebo controlled double blind trial.

Setting General practices in United Kingdom (384), Australia (94), and New Zealand (24).

Participants Postmenopausal women aged 50-69 at randomisation; 3721 women with a uterus were randomised to combined oestrogen and progestogen (n=1862) or placebo (n=1859). Data on health related quality of life at one year were available from 1043 and 1087 women, respectively.

Interventions Conjugated equine oestrogen 0.625 mg plus medroxyprogesterone acetate 2.5/5.0 mg or matched placebo orally daily for one year.

Main outcome measures Health related quality of life and psychological wellbeing as measured by the women’s health questionnaire. Changes in emotional and physical menopausal symptoms as measured by a symptoms questionnaire and depression by the Centre for Epidemiological Studies depression scale (CES-D). Overall health related quality of life and overall quality of life as measured by the European quality of life instrument (EuroQol) and visual analogue scale, respectively.

Results After one year small but significant improvements were observed in three of nine components of the women’s health questionnaire for those taking combined HRT compared with those taking placebo: vasomotor symptoms (P<0.001), sexual functioning (P<0.001), and sleep problems (P<0.001). Significantly fewer women in the combined HRT group reported hot flushes (P<0.001), night sweats (P<0.001), aching joints and muscles (P=0.001), insomnia (P<0.001), and vaginal dryness (P<0.001) than in the placebo group, but greater proportions reported breast tenderness (P<0.001) or vaginal discharge (P<0.001). Hot flushes were experienced in the combined HRT and placebo groups by 30% and 29% at trial entry and 9% and 25% at one year, respectively. No significant differences in other menopausal symptoms, depression, or overall quality of life were observed at one year.

Conclusions Combined HRT started many years after the menopause can improve health related quality of life.

3-Y-O with a Hypothenar Lesion

Infectious Diseases in Children, 8/2008:  A 3-year-old boy presented for evaluation of a painless lesion on his right palm at the hypothenar eminence.

The lesion was first noticed a few months earlier as a small papule and has been growing fairly rapidly. Interestingly, this is occurring in the same location that he previously injured two months earlier with a minor burn that required no evaluation or therapy. However, the patient’s history is complicated by a previous diagnosis of leukemia and he is still receiving chemotherapy with 6-mercaptopurine and methotrexate. His past medical history is otherwise unremarkable.

Figure 1: The lesion was first noticed a few months earlier as a small papule and has been growing fairly rapidly

Figure 2: A large, well-circumscribed fleshy lesion with some dark, pinpoint spots

On examination, a large, well-circumscribed fleshy lesion with some dark, pinpoint spots under a somewhat rough surface and a small area of desquamation at its edge was noted on the hypothenar eminence of his right hand (see figures 1 and 2). The rest of his examination was unremarkable.

What’s your diagnosis?

Answer

Verrucua vulgaris, the common cutaneous wart, which IS a benign soft tissue tumor. The clues include the well-circumscribed lesion with the characteristic “black dots” that are seen on closer examination, which represent small, thrombosed blood vessels, as well as the history of a prior injury to the same area.

I’m sure you all have taken care of children with warts from time to time. However, the fact that this patient has leukemia warrants special mention. Although the immunity to the viruses that cause the various types of warts is not completely understood, it has been known since the advent of chemotherapy for cancer and recognition of other immunodeficiency states decades ago, that common warts in these patients behaved uncommonly. Children with an immunodeficiency, particularly those with cell-mediated deficiencies, have much more difficulty with common cutaneous warts being resistant to therapy and being larger in size and numbers. When I first saw the lesion on the patient presented above, I was not sure of the diagnosis. It took a dermatologist to enlighten me by looking close for some of the features noted above, and couple that with the fact that the child was on chemotherapy.

When I think of the common cutaneous wart, I think of a lesion like  a wart on the knee of my neighbor’s son, just after it had been subjected to cryotherapy, therefore the inflamed look. It has the more characteristic rough, keratotic surface through which you can see a few of the black dots (thrombosed capillaries) mentioned above. Some will respond well with 40% salicylic acid, but this may take several weeks of daily applications. The vast majority will respond to one or two applications of simple cryotherapy or laser therapy. The majority will resolve over a few years of time without any therapy. Some special cases may require a more “toxic” product, such as podophyllin, which is a plant resin that inhibits cell division.

Another option that the dermatologist may use is topical cantharidin, which is a potent vesicant secreted by the blister beetle. This can be carefully applied to the lesion with a small stick or applicator so as not to damage the surrounding skin. This was the treatment used in the case presented. After a series of three applications over a three-month period, the lesion completely sloughed off. Sometimes success in these cases coincides with stopping the chemotherapy long enough for the immune system to recover.

By now, everyone probably knows that of the many different types of human papillomaviruses (>100), that may cause various types of mucocutaneous warts, that certain types are associated with development of genital carcinoma (types 16, 18, 31, 33, 35, 39, 45 and 51). The Merck vaccine, Gardasil, immunizes against types 16 and 18, which make up about 70% of the types that cause cervical cancer, as well as types 6 and 11, which cause about 90% of genital warts, and has been recommended for female patients between the ages of 11 and 26 as a three-dose series. These and other types become even more problematic in immunodeficient cancer patients in that there is even more risk for malignant transformation.

Another HPV-related cancer is verrucous carcinoma, also known as the Ackerman tumor after Lauren V. Ackerman, MD; a leader in surgical pathology during the 20th century, and who described this condition in 1948. This is a variant of a squamous cell carcinoma that occurs mostly in the oral mucosa in areas subjected to chronic inflammation, such as chewing tobacco, mostly in middle-aged to elderly white men (glad I gave up my “Red Man” a long time ago). There appears to be a clear association with HPV and verrucous carcinoma, particularly HPV type 16. You will not likely see this in children, but I thought it was noteworthy in the context of discussing HPV-related cancers. For those interested in more information on the subject of HPV and cancer, the library and internet are loaded with information on HPV and warts.

Molluscum contagiosum is another common childhood cutaneous infection caused by a virus, only this one is a poxvirus (molluscipoxvirus types 1 – 4). The virus causes epidermal cell proliferation, giving it the characteristic fleshy, dome-shaped lesion with a white core that contains the virus. The lesion will become umbilicated as it gets larger. These lesions are easily spread from person to person, and 10 to 15% of children will have these sometime during childhood, especially between 1 and 10 years of age. When they are seen in the anogenital area (figure 5, courtesy of Jim Bass), one must consider the possibility of sexual abuse, although knowing the hand habits of children, it would be easy for these lesions to occur in these places as well through “natural” circumstances. Just need to think about it. Treatment of these lesions, which have no cancer risk, are similar to the treatment of warts noted above, plus one can simply curette them off if the patient will tolerate it. Like warts, these lesions can become very numerous and more difficult to treat in the immunosuppressed patient.

OMNI Postings of 8/24/08

I read that the Democratic National Convention was still going to have John Edwards give a rip-roaring speech this Monday.  However, he declined.  That’s his night to take care of the baby.
But I digress…
1)  Here is the actual link (not the wrong one I sent yesterday) to the concern about giving codeine to some Moms who breast-feed their children.  Codeine’s pain relieving attributes are only activated when it is metabolized, or transformed by the body into morphine. Some individuals have a genetic variance which causes them to metabolize codeine at a rapid rate, producing significantly more morphine in their system than most of the population. While this genetic predisposition is rare, women who possess it and who take codeine for pain while breastfeeding can end up exposing their babies to high levels of morphine through their breast milk. This can cause babies to experience central nervous system depression as a result.
2)  You start with a 36-year-old white male with a history of allergic rhinitis and sinusitis who presented to the emergency room with abdominal pain and diarrhea.  His ultimate diagnosis is Churg-Strauss Syndrome.  Curious as to what the heck that is? 
3)  A boy comes into your ER with a recurrent episode of periorbital swelling, proptosis, headache, decreased vision, and decreased vision.  He gets better on steroids.  A photo, the diagnosis, and a link to the discussion is contained in this posting.
4)  This graph shows you the percentage of measles cases in the US over time and its relation to those cases that were imported from other countries.  A dramatic jump is shown in 2008.
5)  The California president of ACEP wrote a letter to the editor about his “take” on balanced billing.
6)  Amazingly, the Washington Times recently highlighted a resident’s lamentation regarding “bogus” patients who were admitted from the ER who really didn’t have anything wrong with them. He mentions a patient named Irena for whose chest pain he did the million dollar work-up.  She wound up having heart burn.  The resident is upset with how the medical system works.  You’ve got to be kidding me that this newspaper would use this idiot’s story to further the cause of our “inadequate” medical system.  You would think they had better things to do with their ink than to waste it on this tripe, like finding out if that kid belongs to John Edwards. 
7)  79 million adults are struggling to pay health-care bills.  This is according to a new study from The Commonwealth Fund, Losing Ground: How the Loss of Adequate Health Insurance Is Burdening Working Families.  A link to the study is enclosed in the posting.
Regards,
Paul R